annual cash & cash equivalents:
$66.34M+$19.62M(+42.00%)Summary
- As of today (September 9, 2025), SBRA annual cash & cash equivalents is $66.34 million, with the most recent change of +$19.62 million (+42.00%) on December 31, 2024.
- During the last 3 years, SBRA annual cash & cash equivalents has fallen by -$49.55 million (-42.75%).
- SBRA annual cash & cash equivalents is now -88.71% below its all-time high of $587.45 million, reached on December 31, 2017.
Performance
SBRA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$101.65M+$72.75M(+251.77%)Summary
- As of today (September 9, 2025), SBRA quarterly cash & cash equivalents is $101.65 million, with the most recent change of +$72.75 million (+251.77%) on June 30, 2025.
- Over the past year, SBRA quarterly cash & cash equivalents has increased by +$59.34 million (+140.26%).
- SBRA quarterly cash & cash equivalents is now -82.70% below its all-time high of $587.45 million, reached on December 31, 2017.
Performance
SBRA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SBRA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.0% | +140.3% |
| 3 y3 years | -42.8% | +42.1% |
| 5 y5 years | +35.0% | +176.2% |
SBRA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.8% | +42.0% | at high | +251.8% |
| 5 y | 5-year | -42.8% | +42.0% | -81.6% | +251.8% |
| alltime | all time | -88.7% | +586.7% | -82.7% | +1032.2% |
SBRA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $101.65M(+251.8%) |
| Mar 2025 | - | $28.90M(-56.4%) |
| Dec 2024 | $66.34M(+42.0%) | $66.34M(-3.8%) |
| Sep 2024 | - | $68.98M(+63.0%) |
| Jun 2024 | - | $42.31M(-35.8%) |
| Mar 2024 | - | $65.93M(+41.1%) |
| Dec 2023 | $46.72M(-13.4%) | $46.72M(+20.2%) |
| Sep 2023 | - | $38.86M(+20.0%) |
| Jun 2023 | - | $32.38M(-16.3%) |
| Mar 2023 | - | $38.68M(-28.3%) |
| Dec 2022 | $53.93M(-53.5%) | $53.93M(+73.1%) |
| Sep 2022 | - | $31.15M(-56.4%) |
| Jun 2022 | - | $71.52M(+144.3%) |
| Mar 2022 | - | $29.28M(-74.7%) |
| Dec 2021 | $115.89M(+76.9%) | $115.89M(-79.0%) |
| Sep 2021 | - | $551.42M(+645.8%) |
| Jun 2021 | - | $73.94M(+150.7%) |
| Mar 2021 | - | $29.49M(-55.0%) |
| Dec 2020 | $65.52M(+33.3%) | $65.52M(+56.6%) |
| Sep 2020 | - | $41.85M(+13.7%) |
| Jun 2020 | - | $36.80M(-41.0%) |
| Mar 2020 | - | $62.43M(+27.0%) |
| Dec 2019 | $49.14M(-17.6%) | $49.14M(+23.9%) |
| Sep 2019 | - | $39.66M(-31.0%) |
| Jun 2019 | - | $57.47M(+76.1%) |
| Mar 2019 | - | $32.64M(-45.3%) |
| Dec 2018 | $59.66M | $59.66M(-57.2%) |
| Sep 2018 | - | $139.52M(-38.2%) |
| Jun 2018 | - | $225.65M(+287.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $58.17M(-90.1%) |
| Dec 2017 | $587.45M(+1594.6%) | $587.45M(+1254.8%) |
| Sep 2017 | - | $43.36M(+91.5%) |
| Jun 2017 | - | $22.65M(+3.1%) |
| Mar 2017 | - | $21.96M(-36.6%) |
| Dec 2016 | $34.66M(+101.0%) | $34.66M(+20.3%) |
| Sep 2016 | - | $28.82M(-74.5%) |
| Jun 2016 | - | $112.85M(+530.2%) |
| Mar 2016 | - | $17.91M(+3.8%) |
| Dec 2015 | $17.25M(-74.9%) | $17.25M(-56.6%) |
| Sep 2015 | - | $39.71M(+202.3%) |
| Jun 2015 | - | $13.13M(+18.1%) |
| Mar 2015 | - | $11.12M(-83.8%) |
| Dec 2014 | $68.82M(+612.4%) | $68.82M(+114.9%) |
| Sep 2014 | - | $32.02M(+50.9%) |
| Jun 2014 | - | $21.21M(+0.3%) |
| Mar 2014 | - | $21.15M(+118.9%) |
| Dec 2013 | $9.66M(-55.5%) | $9.66M(-90.7%) |
| Sep 2013 | - | $103.45M(+5.0%) |
| Jun 2013 | - | $98.51M(+67.4%) |
| Mar 2013 | - | $58.84M(+171.3%) |
| Dec 2012 | $21.69M(-48.7%) | $21.69M(-39.2%) |
| Sep 2012 | - | $35.67M(+250.2%) |
| Jun 2012 | - | $10.19M(+9.1%) |
| Mar 2012 | - | $9.34M(-85.1%) |
| Dec 2011 | $42.25M | - |
| Sep 2011 | - | $62.70M(+598.4%) |
| Jun 2011 | - | $8.98M(-89.5%) |
| Mar 2011 | - | $85.74M |
FAQ
- What is Sabra Health Care REIT, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sabra Health Care REIT, Inc.?
- What is Sabra Health Care REIT, Inc. annual cash & cash equivalents year-on-year change?
- What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Sabra Health Care REIT, Inc.?
- What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents year-on-year change?
What is Sabra Health Care REIT, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of SBRA is $66.34M
What is the all time high annual cash & cash equivalents for Sabra Health Care REIT, Inc.?
Sabra Health Care REIT, Inc. all-time high annual cash & cash equivalents is $587.45M
What is Sabra Health Care REIT, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, SBRA annual cash & cash equivalents has changed by +$19.62M (+42.00%)
What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SBRA is $101.65M
What is the all time high quarterly cash & cash equivalents for Sabra Health Care REIT, Inc.?
Sabra Health Care REIT, Inc. all-time high quarterly cash & cash equivalents is $587.45M
What is Sabra Health Care REIT, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, SBRA quarterly cash & cash equivalents has changed by +$59.34M (+140.26%)